Cargando…

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study

BACKGROUND: The Kidney Disease: Improving Global Outcomes guidelines advocate the cause–glomerular filtration rate (GFR)–albuminuria (CGA) classification for predicting outcomes. However, there is a dearth of data supporting the use of the cause of chronic kidney disease. This study aimed to address...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamano, Takayuki, Imaizumi, Takahiro, Hasegawa, Takeshi, Fujii, Naohiko, Komaba, Hirotaka, Ando, Masahiko, Nangaku, Masaomi, Nitta, Kosaku, Hirakata, Hideki, Isaka, Yoshitaka, Wada, Takashi, Maruyama, Shoichi, Fukagawa, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923708/ https://www.ncbi.nlm.nih.gov/pubmed/35323977 http://dx.doi.org/10.1093/ndt/gfac134

Ejemplares similares

Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease
por: Hasegawa, Takeshi, et al.
Publicado: (2023)

Hyperbaric area index calculated from ABPM elucidates the condition of CKD patients: the CKD-JAC study
por: Iimuro, Satoshi, et al.
Publicado: (2014)

Correction to: Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
Publicado: (2022)

Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Inaguma, Daijo, et al.
Publicado: (2016)

Analysis of 2897 hospitalization events for patients with chronic kidney disease: results from CKD-JAC study
por: Iimuro, Satoshi, et al.
Publicado: (2019)

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study
por: Nitta, Kosaku, et al.
Publicado: (2018)

Renal Hypoxia in CKD; Pathophysiology and Detecting Methods
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study
por: Akizawa, Tadao, et al.
Publicado: (2021)

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
por: Narita, Ichiei, et al.
Publicado: (2022)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease
por: Román, Juan León, et al.
Publicado: (2021)

J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan
por: Nakagawa, Naoki, et al.
Publicado: (2020)

Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Komaba, Hirotaka, et al.
Publicado: (2021)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
por: Uchiyama-Matsuoka, Natsumi, et al.
Publicado: (2022)

Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)
por: Sofue, Tadashi, et al.
Publicado: (2020)

Effectiveness of CKD Exacerbation Countermeasures in Izumo City
por: Ito, Takafumi, et al.
Publicado: (2021)

Comparison of the Antialbuminuric Effects of Benidipine and Hydrochlorothiazide in Renin-Angiotensin System (RAS) Inhibitor-Treated Hypertensive Patients with Albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) Study
por: Ando, Katsuyuki, et al.
Publicado: (2014)

Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts
por: Canney, Mark, et al.
Publicado: (2023)

Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)
por: Sofue, Tadashi, et al.
Publicado: (2020)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Constipation in CKD
por: Sumida, Keiichi, et al.
Publicado: (2019)

CKD Awareness in the General Population: Performance of CKD-Specific Questions
por: Tuot, Delphine S., et al.
Publicado: (2019)

Acute cardiac overload does not induce cardiac or skeletal expression of fibroblast growth factor 23 in rats
por: Fajol, Abul, et al.
Publicado: (2021)

Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial
por: Obi, Yoshitsugu, et al.
Publicado: (2020)

Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention
por: Goto, Shunsuke, et al.
Publicado: (2008)

CKD Prevalence in the Military Health System: Coded Versus Uncoded CKD
por: Norton, Jenna M., et al.
Publicado: (2021)

Association between serum Na–Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study
por: Maruta, Yuichi, et al.
Publicado: (2018)

Welcome to JACS Au!
por: Jones, Christopher W.
Publicado: (2021)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

CKD in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Frailty in CKD and Transplantation
por: Lorenz, Elizabeth C., et al.
Publicado: (2021)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

The Role of Inflammation in CKD
por: Kadatane, Saurav Prashant, et al.
Publicado: (2023)

Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation
por: Nishida, Kento, et al.
Publicado: (2021)

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
por: Argilés, Àngel, et al.
Publicado: (2013)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes
por: Mullins, C. Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_com1u6ibmvtkr4q7vtautsugcb